Cargando…

Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies

Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before Septem...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Shilin, Shen, Wenya, Cai, Jianning, Jia, Jinhai, Zhao, Dan, Zhang, Shan, Zhao, Xiujun, Ma, Ning, Wang, Wenjuan, Wang, Bingshuang, Zhang, Xiaolin, Liu, Xuehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333535/
https://www.ncbi.nlm.nih.gov/pubmed/35905230
http://dx.doi.org/10.1097/MD.0000000000029318
_version_ 1784758899224608768
author Xue, Shilin
Shen, Wenya
Cai, Jianning
Jia, Jinhai
Zhao, Dan
Zhang, Shan
Zhao, Xiujun
Ma, Ning
Wang, Wenjuan
Wang, Bingshuang
Zhang, Xiaolin
Liu, Xuehui
author_facet Xue, Shilin
Shen, Wenya
Cai, Jianning
Jia, Jinhai
Zhao, Dan
Zhang, Shan
Zhao, Xiujun
Ma, Ning
Wang, Wenjuan
Wang, Bingshuang
Zhang, Xiaolin
Liu, Xuehui
author_sort Xue, Shilin
collection PubMed
description Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail.
format Online
Article
Text
id pubmed-9333535
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-93335352022-08-03 Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies Xue, Shilin Shen, Wenya Cai, Jianning Jia, Jinhai Zhao, Dan Zhang, Shan Zhao, Xiujun Ma, Ning Wang, Wenjuan Wang, Bingshuang Zhang, Xiaolin Liu, Xuehui Medicine (Baltimore) Research Article Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail. Lippincott Williams & Wilkins 2022-07-29 /pmc/articles/PMC9333535/ /pubmed/35905230 http://dx.doi.org/10.1097/MD.0000000000029318 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xue, Shilin
Shen, Wenya
Cai, Jianning
Jia, Jinhai
Zhao, Dan
Zhang, Shan
Zhao, Xiujun
Ma, Ning
Wang, Wenjuan
Wang, Bingshuang
Zhang, Xiaolin
Liu, Xuehui
Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title_full Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title_fullStr Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title_full_unstemmed Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title_short Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
title_sort association between rs735482 polymorphism and risk of cancer: a meta-analysis of 10 case–control studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333535/
https://www.ncbi.nlm.nih.gov/pubmed/35905230
http://dx.doi.org/10.1097/MD.0000000000029318
work_keys_str_mv AT xueshilin associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT shenwenya associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT caijianning associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT jiajinhai associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT zhaodan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT zhangshan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT zhaoxiujun associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT maning associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT wangwenjuan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT wangbingshuang associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT zhangxiaolin associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies
AT liuxuehui associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies